Chemotherapy, for instance, was reported to enhance CCL2-driven (classical) monocyte recruitment and differentiation into tumor-promoting M2 macrophages, thereby reducing the adaptive anti-tumor immunity [104,105]. This evidence concerns the gene CCL2 and neoplasm.